Enhertu improves both progression-free and overall survival in Destiny-Breast04 trial in patients…
First HER2-low metastatic breast cancer phase-III results for AstraZeneca and Daiichi Sankyo’s Enhertu offer potential to redefine…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.